Advanced company searchLink opens in new window

ACORUS THERAPEUTICS LIMITED

Company number 03976183

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
14 Oct 2024 TM01 Termination of appointment of Miguel Angel Pardos Blanco as a director on 30 September 2024
25 Sep 2024 AA Audit exemption subsidiary accounts made up to 31 December 2023
25 Sep 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/23
25 Sep 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/23
25 Sep 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/23
29 Apr 2024 CS01 Confirmation statement made on 16 April 2024 with no updates
14 Oct 2023 AA Audit exemption subsidiary accounts made up to 31 December 2022
14 Oct 2023 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/22
14 Oct 2023 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/22
14 Oct 2023 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/22
21 Apr 2023 CS01 Confirmation statement made on 16 April 2023 with no updates
01 Oct 2022 AA Audit exemption subsidiary accounts made up to 31 December 2021
01 Oct 2022 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/21
01 Oct 2022 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/21
01 Oct 2022 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/21
08 Jun 2022 TM01 Termination of appointment of Christopher Paul Spooner as a director on 31 May 2022
26 May 2022 AP01 Appointment of Mr Miguel Angel Pardos Blanco as a director on 28 April 2022
26 May 2022 TM01 Termination of appointment of Alan Musgrave Olby as a director on 13 May 2022
29 Apr 2022 CS01 Confirmation statement made on 16 April 2022 with no updates
29 Sep 2021 AA Audit exemption subsidiary accounts made up to 31 December 2020
29 Sep 2021 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/20
29 Sep 2021 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/20
29 Sep 2021 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/20
20 Apr 2021 CS01 Confirmation statement made on 16 April 2021 with no updates
20 Apr 2021 PSC05 Change of details for Is Pharma Ltd as a person with significant control on 16 April 2018